Universe Pharmaceuticals INC Receivables

Universe Pharmaceuticals INC (UPC) currently reports a receivables of $13M as of September 2025. That compares with $18M in the prior-year period — down 26.2% year over year. Use the charts on this page to explore Universe Pharmaceuticals INC's receivables history and peer comparisons.

Universe Pharmaceuticals INC's receivables decreased from $18M to $13M — a 26.2% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Universe Pharmaceuticals INC reported $13M in receivables as of September 2025. That compares with $18M in the prior-year period — down 26.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Universe Pharmaceuticals INC, and consider following UPC for alerts when major investors trade the stock.

Universe Pharmaceuticals INC is classified in the Healthcare sector. On receivables, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing UPC with unrelated industries.